INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 250 participants.
Also called NCT06965504
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 250 participants
- Sponsor
- Registry
-
NCT06965504
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06965504. Allocation not applicable; no masking; primary purpose treatment. Start 2026-10-02 (actual); primary completion 2028-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
- Acronym
- INTeGRATE
- Condition
- Heart Failure
- Condition
- Cardiogenic Shock
- Condition
- Reduced Ejection Fraction Heart Failure
- Intervention (Device)
- Impella 5.5 SmartAssist
- Lead sponsor
- Abiomed Inc.
- Collaborator
- Johnson & Johnson
Record details
- Record id
cardio:ct-nct06965504- Content hash
c421629109befaf1fccdf0caa41339bc6a2e8709bb559282135ab17aee882bcc